How AI-Powered Phenotyping Enhances the Patient Journey for Life Science Applications
In this episode of tHEORetically Speaking, Dr. Joseph Zabinksi, VP and Head of Commercial Strategy and AI at OM1, explains how AI-powered digital phenotyping can enhance our understanding of patients' experiences and inform access, treatment, and condition management.
Entyvio: New Subcutaneous Option for Crohn’s Disease Patients
Takeda's Entyvio, a medication for Crohn's disease, has been approved for a subcutaneous (SC) formulation. Originally [...]
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
FDA Reports Extended Shortages for Eli Lilly’s Diabetes Drug Mounjaro
The U.S. Food and Drug Administration (FDA) announced that shortages of Eli Lilly’s diabetes medication, Mounjaro, [...]
Sanofi Settles Zantac Litigation in U.S. State Courts
Sanofi has reached a settlement to resolve around 4,000 personal injury lawsuits linked to its heartburn [...]
Switzerland’s Progressive Approach to Opioid Addiction Treatment: A Model for Success
In Zurich, Switzerland, the Arud Centre for Addiction Medicine offers a pioneering approach to opioid addiction, [...]
Expanded Coverage for Anti-Obesity Drugs in U.S. Government Health Programs
The Centers for Medicare and Medicaid Services (CMS) has issued guidance for Medicare Part D plans [...]
U.S. Drug Overdose Deaths Hit Record High in 2022, Showing Signs of Stabilizing Crisis
The U.S. saw a record 107,941 drug overdose deaths in 2022, a slight rise from the [...]
The Evolution and Future of CAR-T Cell Therapies: Overcoming Manufacturing Hurdles for Cancer Treatment
In the summer of 2017, Novartis took a significant step in cancer treatment with the approval [...]
The Experimental Quest for Longevity: Rapamycin’s Rising Popularity
At 77, David Sandler from Bergen County, N.J., has ventured into an experimental approach to longevity [...]
Podcast Q&A: Clinical Outcomes Assessments and Training
In this episode of tHEORetically Speaking, join Kelly Lipman, Heather Dickerson, and Ryan Murphy from ICON, who answer questions from a recent webinar on the dynamic landscape of clinical outcomes assessments, examining their historical significance, current uses and best practices, and making a case for greater standardization in their implementation.
Amazon and Eli Lilly Partner for Telehealth Medication Delivery Amid Drug Shortages
Amazon has partnered with Eli Lilly to distribute select medications, including GLP-1 drugs Mounjaro and Zepbound, [...]
Podcast Q&A: Clinical Outcome Assessment (COA) Translations
In this episode of tHEORetically Speaking, join Christelle Giroudet, MA and Ana Alvarez, MA, COA Linguistic Validation Leaders with ICON, as they highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Beyfortus: A New Milestone in RSV Prevention for Young Children
Beyfortus, a newly developed monoclonal antibody product by AstraZeneca and Sanofi, has shown a remarkable 90% [...]
Human Factors and User Experience for Medical Device Design
Designing for Testing, Regulatory Compliance and Optimal User and Patient Outcomes
Gilead Halts Magrolimab Blood Cancer Development After Increased Mortality Risk
Gilead Sciences is halting the development of magnolia for blood cancer, including acute myeloid leukemia (AML) [...]
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
In this webinar, panelists address integrating patient-centered research into real-world studies, focusing on diversity, equity, and inclusion (DEI), and developing systemic approaches for a more equitable research ecosystem.
Incorporating SOGIE Data in Health Systems: Addressing LGBTQ+ Health Disparities
Researchers are advocating for the inclusion of SOGIE (Sexual Orientation, Gender Identity, and Expression) data in [...]
Can We Trust the Data? The Case for Validation
Real world research has produced recent newsworthy findings on topics as diverse as COVID, mental health, cancer, and dementia. [...]
Global Study Reveals High Use of Unregulated Weight-Loss Products Among Teens: Urgent Need for Action
Nearly 1 in 10 teenagers around the world are resorting to risky, unregulated weight-loss products like [...]
Recent Developments in Healthcare and Pharmaceutical Industry: CVS Health’s Decision, Insulin Price Cap, Alzheimer’s Research, FDA Investigations, and AI Prescription Assistant Launch
CVS Health Removing Humira from Some Drug Lists: CVS Health plans to drop AbbVie’s rheumatoid arthritis [...]
Fatal Flaw: The Tragic Case of Carlton Gautney and the Investigation into Medical Device Malfunctions
Carlton "PeeWee" Gautney Jr., a 59-year-old Alabama police dispatcher and diabetes patient, depended on a Medtronic [...]
Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults
Watch this webinar on addressing early onset cancer through strategic trial design, targeted launch indications, and increased trial access to speed up the delivery of impactful treatments.
Shifting the Paradigm to Pragmatic Evidence Generation
By: Richard Gliklich, MD, OM1 & Sonja Wustrack, MPH, OM1 Integrated Evidence Generation Integrated evidence generation (IEG) is a framework [...]
Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity
In January 2010, the FDA approved Novo Nordisk's Victoza (liraglutide), a GLP-1 receptor agonist for Type [...]
